Pharmacokinetic profile of loprazolam in 12 young and 12 elderly healthy volunteers

Drugs under Experimental and Clinical Research

Volumn 27, Issue 4, 2001, Pages 151-159

  Dorling, M C ^a   Hindmarch, I ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LOPRAZOLAM;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DROWSINESS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FATIGUE; FEMALE; HEADACHE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; INSOMNIA; MALE; NORMAL HUMAN; PAIN; SOLID PHASE EXTRACTION; STEADY STATE; VERTIGO;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ANXIETY AGENTS; AREA UNDER CURVE; BENZODIAZEPINES; BIOLOGICAL AVAILABILITY; DIZZINESS; FATIGUE; HALF-LIFE; HEADACHE; HUMANS; MIDDLE AGED; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP STAGES;

EID: 0035687456     PISSN: 03786501     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Use and abuse of the benzodiazepines
2. Minor tranquillisers, sedatives and hypnotics
3. Hypnotics and sedatives
4. Long-term benzodiazepine use by elderly people living in the community
5. Long-term continuous use of benzodiazepine by older adults in Quebec: Prevalence, incidence and risk factors
6. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I)
7. Benzodiazepines: A summary of pharmacokinetic properties
8. Psychopharmacological properties of antidepressants with particular reference to Moclobemide and the elderly
9. Benzodiazepines and the risk of falls in nursing home residents
10. Benzodiazepine use among the elderly in the community
11. Psychoactive medication use, sensorimotor function and falls in older women
12. The use of anti-depressant and benzodiazepines in perpetrators and victims of accidents
13. Benzodiazepines for insomnia in communitydwelling elderly: A review of benefit and risk
14. Aspects of short-term use of two benzodiazepine hypnotics in the elderly
15. Drugs and falls in older people: A systematic review and meta-analysis. I. Psychotropic drugs
16. The effect of age on the pharmacokinetics and pharmacodynamics of midazolam
17. Pharmacokinetics and the pharmacodynamic action of midazolam in young and elderly patients undergoing tooth extraction
18. Diazepam tolerance: Effect of age, regular sedation and alcohol
19. An evaluation of the shortterm hypnotic efficacy of loprazolam in comparison with nitrazepam in elderly patients
20. Loprazolam - A multicentre dose-ranging study in general medical and pre-operative patients
21. Loprazolam. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in insomnia
22. Clinical and psychometric evaluation of two doses of loprazolam and placebo in geriatric patients
23. A multicentre hospital study to compare the hypnotic efficacy of loprazolam and nitrazepam
24. Single and repeated dose kinetics of the hypnotic agent loprazolam in healthy volunteers
25. Correlation of the clinical pharmacodynamics of loprazolam with serum concentration
26. Residual effects of hypnotics: An update
27. Long term efficacy and tolerability of a new hypnotic loprazolam
28. A comparison of the hypnotic activity of loprazolam, temazepam and placebo in general practice
29. Comparative hypnotic activity of single doses of loprazolam, flurazepam and placebo
30. Temporal variation in triazolam pharmacokinetics and pharmacodynamics after oral administration
31. Circadian changes of valproate kinetics depending on meal conditions in humans
32. Effect of after-dinner administration on the pharmacokinetics of oral flunitrazepam and loprazolam
33. Pharmacokinetics and pharmacodynamics following single and repeated nightly administrations of loprazolam, a new benzodiazepine hypnotic
34. Electron-capture gas chromatographic determination of loprazolam in plasma and a pharmacokinetic application
35. A clinical trial of a new hypnotic Loprazolam
36. Pharmacokinetics of loprazolam and its principal metabolite in young subjects and elderly hospital patients
37. Pharmacokinetics in old age: Principles and problems of assessment
38. Drug dosage in the elderly
39. Antipyrine kinetics in the elderly: Prediction of age-related changes in benzodiazepine oxidising capacity
40. Aging and the liver: An update
41. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
42. Age and gender-related differences in diazepam pharmacokinetics
43. The effect of age on the pharmacokinetics of diazepam
44. Effect of age and sex on disposition of desmethyldiazepam formed from its precursor clorazepate
45. Hypnotic benzodiazepines: Relationship between sleep parameters and pharmacokinetics of loprazolam
46. Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly
47. Diurnal variation in clobazam kinetics in man
48. Time of day effects on diazepam kinetics after oral dosing
49. Time-dependence in benzodiazepine pharmacokinetics. Mechanisms and clinical significance
50. Unchanged protein binding and the increase of serum diazepam levels after food intake
51. Fatty acids modulation of meal-induced variations in diazepam free fraction
52. Diurnal variations in plasma diazepam concentrations associated with reciprocal changes in free fraction
53. Comparative kinetics and response to the benzodiazepines agonists triazolam and zolpidem: Evaluation of sex-dependent differences